SEC 13F Intelligence

Dundas Partners LLP / ABT

Dundas Partners LLP’s Abbott Laboratories Position

Does Dundas Partners LLP own Abbott Laboratories (ABT)? Yes — 423.9K shares worth $44M (+3.47% of its 13F portfolio) as of Q1 2026, down from 428.3K shares the prior filed quarter.

Position Value
$44M
Q1 2026
Shares
423.9K
% of Portfolio
+3.47%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $20MQ4 ’18Q1 ’19: $16MQ2 ’19: $18MQ3 ’19: $17MQ4 ’19: $18MQ4 ’19Q1 ’20: $16MQ2 ’20: $19MQ3 ’20: $23MQ4 ’20: $28MQ4 ’20Q1 ’21: $25MQ2 ’21: $24MQ3 ’21: $25MQ4 ’21: $28MQ4 ’21Q1 ’22: $34MQ2 ’22: $31MQ3 ’22: $28MQ4 ’22: $31,722Q4 ’22Q1 ’23: $29,121Q2 ’23: $31,353Q3 ’23: $31,315Q4 ’23: $35,589Q4 ’23Q1 ’24: $36,750Q2 ’24: $34,313Q3 ’24: $39MQ4 ’24: $39MQ4 ’24Q1 ’25: $46MQ2 ’25: $51MQ3 ’25: $59MQ4 ’25: $54MQ4 ’25Q1 ’26: $44Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026423.9K$44M+3.47%
Q4 2025428.3K$54M+3.78%
Q3 2025443.0K$59M+4.19%
Q2 2025371.7K$51M+3.51%
Q1 2025345.0K$46M+3.37%
Q4 2024345.0K$39M+2.74%
Q3 2024345.0K$39M+2.83%
Q2 2024330.2K$34,313+2.66%
Q1 2024323.3K$36,750+2.89%
Q4 2023323.3K$35,589+3.10%
Q3 2023323.3K$31,315+3.08%
Q2 2023287.6K$31,353+2.95%
Q1 2023287.6K$29,121+3.05%
Q4 2022288.9K$31,722+3.45%
Q3 2022284.2K$28M+3.20%
Q2 2022284.2K$31M+3.34%
Q1 2022284.2K$34M+3.06%
Q4 2021224.6K$28M+3.53%
Q3 2021208.5K$25M+3.48%
Q2 2021208.5K$24M+3.51%
Q1 2021208.5K$25M+3.97%
Q4 2020208.5K$28M+4.04%
Q3 2020208.5K$23M+4.55%
Q2 2020208.5K$19M+4.17%
Q1 2020208.5K$16M+4.32%
Q4 2019208.5K$18M+4.10%
Q3 2019208.5K$17M+4.35%
Q2 2019208.5K$18M+4.10%
Q1 2019205.8K$16M+4.02%
Q4 2018205.8K$20M+4.33%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dundas Partners LLP’s full portfolio or all institutional holders of ABT.